HOME >> BIOLOGY >> NEWS
New discovery: 'footprint' shows master switch simultaneously controls plants' disease defenses

CHAPEL HILL -- Plants respond to infections by activating one or more genetic "master switches" that in turn simultaneously control scores of genes that protect the plants against disease, scientists at the University of North Carolina at Chapel Hill and Syngenta of Research Triangle Park, N.C., have discovered. Until recently, Syngenta was called Novartis Agribusiness Research Inc.

"Because their core sets of genes are so similar, a genetic 'footprint' like the one we found could be a binding site for a universal switch for the immune system among many plant species," said Dr. Jeffery L. Dangl, John N. Couch associate professor of biology at UNC-CH. "This discovery, on this scale, is a first for plant biology."

Working with Arabidopsis, a member of the mustard family widely considered the "laboratory mouse" of the plant kingdom, the scientists analyzed expression of about 8,000 plant genes and tested them under 14 different conditions that either turned on or turned off the plant's immune system. New genomics technology enabled them for the first time to simultaneously test the large group of genes, which are a third of the total number of genes in Arabidopsis.

"We found a small group of about 30 genes that all behaved the same way under the different treatments we subjected them to," Dangl said. "That meant that they were responding to something in common. We found that each gene in this group has one short sequence of DNA, in essence a footprint, in a position called the promoter, which controls when the genes are turned on and off. "

A report on the discovery appears in the Dec. 1 issue of Nature Genetics, a major scientific journal. Besides Dangl, other UNC-CH authors are former undergraduate Aaron Levine and postdoctoral fellow Dr. Thomas Eulgem. Syngenta authors are Drs. Klaus Maleck, Allen Morgan, Jurg Schmid, Kay Lawton and Robert A. Dietrich, a former postdoctoral fellow at UNC-CH.

Among the 30-gene group, the resea
'"/>

Contact: David Williamson
David_Williamson@unc.edu
919-962-8596
University of North Carolina at Chapel Hill
27-Nov-2000


Page: 1 2

Related biology news :

1. Destination discovery: Unleashing your research potential
2. New map shows human footprint covers most of the Earth
3. New study shows hope for treating inhalant abuse
4. Chemical derived from vitamin-E shows early promise as cancer drug
5. Cancer vaccine based on pathogenic listeria bacteria shows promise targeting metastases
6. Trial shows which brain cancer patients benefit from temozolomide
7. New research shows plants can shuffle and paste gene pieces to generate genetic diversity
8. Preclinical safety study shows adipose-derived stem cells improve heart function after heart attack
9. Simian virus 40 not associated with non-Hodgkin lymphoma, study shows
10. A probable cause for high blood pressure identified - shows links with diabetes
11. Blue marlin in gulf have high mercury levels, A&M study shows

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/22/2020)... Ore. (PRWEB) , ... April 21, 2020 , ... ... from Ideaship, a patent leveraged venture capital firm that provides patent development support ... platforms to detect and treat illnesses such as ovarian cancer and precancerous pancreatic ...
(Date:4/18/2020)... , ... April 16, 2020 , ... SIRION Biotech ... cell therapy, today announced it will present a company update on its work expediting ... Summit taking place on April 22 and 23. Dieter Lingelbach, the Company’s Chief ...
(Date:4/16/2020)... ... April 15, 2020 , ... RoosterBio Inc., a ... bioprocess systems, announces that the Medical Technology Enterprise Consortium (MTEC) recognized a multi-institution ... Meeting in March. The Regenerative Medicine (RegenMed) biomanufacturing collaboration had created a team ...
Breaking Biology News(10 mins):
(Date:5/14/2020)... ... May 12, 2020 , ... NanoString ... bringing together thousands of industry leaders, clinicians, research scientists, medical professionals and academics ... Carl June, MD, Director of the Center for Cellular Immunotherapies at the Perelman ...
(Date:5/5/2020)... ... May 04, 2020 , ... Red ... life sciences industry, today announced that Informa Training Partners, a life sciences training ... to Red Nucleus Boston, effective immediately. , “The name change solidifies a stronger ...
(Date:4/26/2020)... NEW YORK (PRWEB) , ... April 23, 2020 ... ... in the Azure Marketplace today, an online store providing applications and services for ... organizations with certain well-defined business needs to sign up online for a built-for-purpose ...
(Date:4/22/2020)... ... 21, 2020 , ... Ripple Science today announced new initiatives ... are working remotely and have paused patient visits, forcing teams to do more ... during this uncertain time by giving research teams free access to Ripple for ...
Breaking Biology Technology:
Cached News: